Cagrilintide (10mg)

Login to view prices.

Existing research has found the following:

  • Supports Appetite Regulation Research – Studied for its potential to activate amylin receptors involved in satiety and food intake control.

  • Explores Metabolic & Glycemic Pathways – Investigated for improving glucose regulation and enhancing insulin sensitivity in experimental models.

  • Evaluates Cardiometabolic Health Effects – Examined for its influence on lipid metabolism and potential reduction of cardiovascular risk markers.

INTERNATIONAL SHIPPING

100% SECURE CHECKOUT

Description

Appetite Regulation and Energy-Balance Research

  • Cagrilintide is a long-acting amylin analog studied in pre-clinical and cellular models for its ability to modulate satiety signaling via amylin and calcitonin receptors in the central nervous system, providing a framework for research into appetite control and energy-balance mechanisms.

Metabolic-Function and Insulin-Sensitivity Studies

  • In animal and in-vitro systems, Cagrilintide has been observed to improve insulin sensitivity and glucose homeostasis, making it a useful model for studying peptide-regulated metabolic control and glycemic balance.

Cardiometabolic and Vascular-Health Models

  • Experimental data suggest that Cagrilintide may influence cardiovascular biomarkers and lipid metabolism, supporting its use in studies of cardiometabolic risk reduction and vascular-function regulation.

Energy-Expenditure and Lipid-Metabolism Research

  • Pre-clinical findings indicate Cagrilintide enhances energy expenditure while modulating lipid oxidation, allowing detailed examination of adipose-tissue regulation and systemic metabolic efficiency.

Type 2 Diabetes and Glucose-Regulation Models

  • Cagrilintide has been evaluated for its impact on glucose control and pancreatic hormone dynamics in non-clinicaldiabetes research models, contributing to the understanding of amylin receptor pharmacology and insulin secretion.

Synergistic Research with GLP-1 Receptor Agonists

  • Laboratory studies frequently examine Cagrilintide in combination with GLP-1 analogs such as Semaglutide, investigating synergistic pathways in satiety regulation, glycemic control, and weight-management mechanisms.

Gastrointestinal and Motility Studies

  • Experimental models have demonstrated Cagrilintide’s ability to delay gastric emptying and modulate gut motility, supporting its use in digestive-system and nutrient-absorption research.

Neuroprotective and Cognitive Function Research

  • Emerging pre-clinical evidence suggests amylin analogs may influence neuronal energy metabolism and synaptic plasticity, providing a potential research tool for studying neurodegeneration and cognitive-function pathways.

STORAGE DETAILS

Lyophilized Cagrilintide peptide is stable at room temperature for 90 days; however, it should NOT be stored below freezing for any extended period of time. After reconstituting, Cagrilintide should be refrigerated at temperatures not to exceed 36°F.

Product Specifications

  • Appearance: Solid, white powder in 3mL glass ampule

  • Chemical Formula: C277H434N76O83

  • PubChem CID: (Specify if available)

  • CAS Number: 2249740-17-6

  • Molecular Weight: ~6117.07 g/mol

  • Synonyms: Cagrilintide, 2249740-17-6, AM833

  • Storage: Store at ≤6°C, sealed, away from heat, light, and moisture.

  • Concentration: ≥98%

    Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding appetite suppression, glucose control, or cardiovascular benefits in humans. End-user assumes responsibility for determining suitability for specific research protocols.

You may also like